Robust and validated models to predict high risk of non-sentinel node metastases in breast cancer patients with micrometastases or isolated tumor cells in the sentinel node

Acta Oncologica

Volumn 53, Issue 2, 2014, Pages 209-215

  Tvedskov, Tove F ^a   Jensen, Maj Britt ^b   Balslev, Eva ^c   Kroman, Niels ^a  

^a Copenhagen University Hospital ^*  (Denmark)

^b Danish Breast Cancer Cooperative Group   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER CELL; CANCER PATIENT; CANCER RISK; CELL ISOLATION; CONTROLLED STUDY; EPIDEMIOLOGY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MICROMETASTASIS; MIDDLE AGED; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE METASTASIS; VALIDATION STUDY; CANCER SIZE; CANCER SURGERY; DENMARK; HIGH RISK POPULATION; ISOLATED TUMOR CELL; LOW RISK POPULATION; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; NON SENTINEL NODE METASTASIS; PREDICTION; RISK FACTOR; TUMOR CELL;

AREA UNDER CURVE; BREAST NEOPLASMS; COHORT STUDIES; DENMARK; FEMALE; HUMANS; LYMPHATIC METASTASIS; MODELS, BIOLOGICAL; NEOPLASM MICROMETASTASIS; RISK FACTORS; ROC CURVE; SENTINEL LYMPH NODE BIOPSY;

EID: 84892173809     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2013.806993     Document Type: Article

References (26)

1. Jensen M B , B alslev E , E jlertsen B , K roman N . Stage migration after introduction of sentinel lymph node dissection in breast cancer treatment in Denmark: A nationwide study . Eur J Cancer 2011 ; 47 : 872-8
2. Croshaw R L , E rb K M , S hapiro-Wright H M , J ulian T B . T he need for axillary dissection in patients with positive axillary sentinel lymph nodes . Curr Oncol Rep 2011 ; 13 : 5-10
3. Bilimoria KY , B entrem DJ , H ansen NM , Bethke KP , Rademaker AW , Ko CY , et al . Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer . J Clin Oncol 2009 ; 27 : 2946-53
4. Yi M , G iordano SH , M eric-Bernstam F , M ittendorf EA , Kuerer HM , Hwang RF , et al . Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs . SLNB with axillary lymph node dissection for node-positive breast cancer patients: Experience from the SEER database. Ann Surg Oncol 2010 ; 17 : 343-51
5. Galimberti V , C ole B F, Z urrida S , V iale G , L uini A , Veronesi P , et al . Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): A phase 3 randomised controlled trial . Lancet Oncol 2013 ; 14 : 297-305
6. Giuliano AE , H unt KK, B allman KV , B eitsch PD , Whitworth PW , Blumencranz PW , et al . Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: A randomized clinical trial . JAMA 2011 ; 305 : 569-75
7. Giuliano A E , M cCall L, B eitsch P , W hitworth PW , Blumencranz P , Leitch AM , et al . Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: The American College of Surgeons Oncology Group Z0011 randomized trial . Ann Surg 2010 ; 252 : 426-32
8. Pepels MJ , V estjens JH, d e B M , S midt M , v an Diest PJ , Borm GF , et al . Safety of avoiding routine use of axillary dissection in early stage breast cancer: A systematic review . Breast Cancer Res Treat 2011 ; 125 : 301-13
9. Van Zee KJ, M anasseh DM , B evilacqua JL, B oolbol SK , Fey JV , Tan LK , et al . A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy . Ann Surg Oncol 2003 ; 10 : 1140-51
10. C, O livier C, L ambaudie E, F ondrinier E, Marchal F , Guillemin F , et al . Comparison of models to predict nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: A prospective multicenter study . J Clin Oncol 2009 ; 27 : 2800-8
11. Houvenaeghel G , N os C, G iard S , M ignotte H, E sterni B, Jacquemier J , et al . A nomogram predictive of non-sentinel lymph node involvement in breast cancer patients with a sentinel lymph node micrometastasis . Eur J Surg Oncol 2009 ; 35 : 690-5
12. Meretoja T J , S trien L, H eikkila PS , L eidenius MH . A simple nomogram to evaluate the risk of nonsentinel node metastases in breast cancer patients with minimal sentinel node involvement . Ann Surg Oncol 2012 ; 19 : 567-76
13. Tvedskov T F , J ensen MB , L isse IM , E jlertsen B, B alslev E, Kroman N . High risk of non-sentinel node metastases in a group of breast cancer patients with micrometastases in the sentinel node . Int J Cancer 2012 ; 131 : 2367-75
14. Christiansen P , F riis E , B alslev E , J ensen D , M oller S . Sentinel node biopsy in breast cancer: Five years ' experience from Denmark . Acta Oncol 2008 ; 47 : 561-8
15. Singletary S E , A llred C , A shley P , B assett L W , B erry D , Bland KI , et al . Revision of the American Joint Committee on Cancer staging system for breast cancer . J Clin Oncol 2002 ; 20 : 3628-36
16. Moller S , J ensen MB , E jlertsen B , B jerre KD , L arsen M , Hansen HB , et al . The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise . Acta Oncol 2008 ; 47 : 506-24
17. Kwon Y , R o J, K ang HS , K im SK , H ong EK, K hang SK , et al . Clinicopathological parameters and biological markers predicting non-sentinel node metastasis in sentinel nodepositive breast cancer patients . Oncol Rep 2011 ; 25 : 1063-71
18. Tvedskov TF , B artels A , J ensen M B , P aaschburg B , Kroman N , Balslev E , et al . Evaluating TIMP-1, Ki67, and HER2 as markers for non-sentinel node metastases in breast cancer patients with micrometastases to the sentinel node . APMIS 2011 ; 119 : 844-52
19. Houvenaeghel G , B annier M , N os C , G iard S , M ignotte H, Jacquemier J , et al . Non sentinel node involvement prediction for sentinel node micrometastases in breast cancer: Nomogram validation and comparison with other models . Breast 2012 ; 21 : 204-9
20. Goldhirsch A , W ood WC, C oates A S , G elber RD , Thurlimann B , Senn HJ . Strategies for subtypes-dealing with the diversity of breast cancer: Highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 . Ann Oncol 2011; 22 : 1736-47
21. Pepels MJ , de BM, B ult P , v an Dijck JA , v an Deurzen CH, Menke-Pluymers MB , et al . Regional recurrence in breast cancer patients with sentinel node micrometastases and isolated tumor cells . Ann Surg 2012 ; 255 : 116-21
22. Noguchi M . A voidance of axillary lymph node dissection in selected patients with node-positive breast cancer . Eur J Surg Oncol 2008 ; 34 : 129-34
23. Andersson Y , F risell J , de BJ, B ergkvist L . P rediction of nonsentinel lymph node status in breast cancer patients with sentinel lymph node metastases: Evaluation of the tenon score . Breast Cancer (Auckl.) 2012 ; 6 : 31-8
24. Hessman CJ, N aik A M , K earney NM , J ensen A J , D iggs BS , Troxell ML , et al . Comparative validation of online nomograms for predicting nonsentinel lymph node status in sentinel lymph node-positive breast cancer . Arch Surg 2011 ; 146 : 1035-40
25. Kocsis L, S vebis M , B oross G , S inko M , M araz R , R ajtar M , et al . Use and limitations of a nomogram predicting the likelihood of non-sentinel node involvement after a positive sentinel node biopsy in breast cancer patients . Am Surg 2004 ; 70 : 1019-24
26. Chen K, Z hu L, J ia W, R ao N , F an M , H uang H, et al . Validation and comparison of models to predict non-sentinel lymph node metastasis in breast cancer patients . Cancer Sci 2011 ; 103 : 274-81 .